Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 62

Sort by

Sort Order Select

Journal Articles

Validation of the Ottawa Score in Cancer Patients with Venous Thromboembolism. the Predicare Cohort Study

Guy Meyer, Celine Chapelle, Philippe Girard, MD, Florian Scotté, MD PhD, Anne Lamblin, Silvy Laporte, MS, PhD

Blood (2019) 134 (Supplement_1): 167.

https://doi.org/10.1182/blood-2019-129087

Published: 2019

Journal Articles

Updated Meta-Analysis of Randomized Controlled Trials on Primary Ambulatory Thromboprophylaxis (PATP) in Patients with Locally Advanced or Metastatic Lung Cancer Receiving Chemotherapy

Kyaw Zin Thein, MDMBBS, Lukman Tijani, MD, Thein H. Oo, MD

Blood (2019) 134 (Supplement_1): 2435.

https://doi.org/10.1182/blood-2019-123144

Published: 2019

Journal Articles

Impact of Primary Ambulatory Thromboprophylaxis (PATP) with Low-Molecular Weight Heparins (LMWHs) on Survival in Patients with Locally Advanced or Metastatic Lung Cancer (LC) Receiving Chemotherapy

Kyaw Zin Thein, MDMBBS, Lukman Tijani, MD, Thein H. Oo, MD

Blood (2019) 134 (Supplement_1): 3466.

https://doi.org/10.1182/blood-2019-128561

Published: 2019

Journal Articles

Impact of Anticoagulant and Antiplatelet on the Thrombotic Risk in Cancer Associated Thrombosis

Shaker A Mousa, PhD BPharm, MBA, MSc, Kavitha Godugu, PhD, Noureldien Hassan Elsayed Darwish, MDPhDBS, Sharan Krishnappan, Anjali Bhave

Blood (2019) 134 (Supplement_1): 3677.

https://doi.org/10.1182/blood-2019-130426

Published: 2019

Journal Articles

Use of Anticoagulants of Patients with Cancer-Associated Thrombosis Beyond 6 Months ; The Uscat Study, a 432-Patient Retrospective Non-Interventional Study

Isabelle Mahe, MD PhD, Ludovic Plaisance, MD, Céline Chapelle, Silvy Laporte, MS, PhD, Benjamin Planquette, MD PhD, Laurent Bertoletti, MD PhD, Jean Chidiac, MD, Francis Couturaud, MD PhD, Lionel Falchiero, MD, Nicolas Falvo, MD, Isild Mahé, Hélène Helfer, PhD, Guy Meyer

Blood (2019) 134 (Supplement_1): 3664.

https://doi.org/10.1182/blood-2019-124745

Published: 2019

Journal Articles

Venous Thromboembolic Disease and Bone Marrow Transplant: A Remarkable Cause of Mortality and Morbidity — Potentially Preventable

Marta Rivas Luque, Estefanía Morente Constantin, Pablo Romero Garcia, Maria Almudena Garcia-Ruiz, Manuel Jurado, MD PhD

Blood (2018) 132 (Supplement 1): 5070.

https://doi.org/10.1182/blood-2018-99-113780

Published: 2018

Journal Articles

Multi-Modal Mechanisms and Anti-Sickling of Novel Sulfated Non-Anticoagulant Low Molecular Weight Heparin in Sickle Cell Disease

Shaker A Mousa, PhD BPharm, MBA, MSc, Noureldien Hassan Elsayed Darwish, MDPhDBS, Vandhana Muralidharan-Chari, PhD, Mohamed Qari, MD, Chen Qiukan, J Eric Russell, MD, Osheiza Abdulmalik, DVM

Blood (2018) 132 (Supplement 1): 265.

https://doi.org/10.1182/blood-2018-99-115121

Published: 2018

Journal Articles

Tackling Cancer Associated Thrombosis: A Multi-Professional Approach

Sumantha Gabriel, BPharm, Kate Musgrave, BA, MBBS, MRCP

Blood (2018) 132 (Supplement 1): 4691.

https://doi.org/10.1182/blood-2018-99-112538

Published: 2018

Journal Articles

Low- Molecular Weight Heparins (LMWH) Versus Vitamin K Antagonists (VKAs) in the Treatment and Secondary Prevention of Cancer-Associated Venous Thromboembolism (VTE): A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs)

Kyaw Zin Thein, MD MBBS, Lukman Tijani, MD, Thein H. Oo, MD FACP, FRCP

Blood (2016) 128 (22): 1180.

https://doi.org/10.1182/blood.V128.22.1180.1180

Published: 2016

Journal Articles

Endothelial Protective Properties of Low Molecular Weight Heparin (LMWH) Tinzaparin in Combination with Statin: A Novel Potential Therapeutic Tool in Preventing Cancer Metastasis?

Barry Kevane, MB, Karl Egan, PhD, Seamus Allen, PhD, Patricia Maguire, PhD, Elaine Neary, MD, Áine Lennon, BSc, Fionnuala Ní Áinle, MD PhD

Blood (2016) 128 (22): 881.

https://doi.org/10.1182/blood.V128.22.881.881

Published: 2016

Journal Articles

Safety of Weight-Adjusted Dosing of LMWH in Clinically Obese Cancer Patients with Venous Thromboembolism

Gillian Mount, MD MSc, Michael J. Kovacs, MD FRCPC, Alejandro Lazo-Langner, MD MSc, FRCPC, Lenicio Siqueira, BSc, Martha L Louzada, MD

Blood (2016) 128 (22): 882.

https://doi.org/10.1182/blood.V128.22.882.882

Published: 2016

Journal Articles

The Risk of Major Bleeding with Low-Molecular-Weight-Heparins for Venous Thromboembolism in Dialysis Patients: The Q-VTE Study

Adi J. Klil-Drori, MD, Janie Coulombe, MSc, Sharon J. Nessim, MD MSc, Vicky Tagalakis, MD MSc

Blood (2016) 128 (22): 89.

https://doi.org/10.1182/blood.V128.22.89.89

Published: 2016

Journal Articles

Serial Trough Anti-Xa Levels to Assess Low Molecular Weight Heparin Accumulation in Patients with Chronic Kidney Disease: Analysis of Crcl <30 Ml/Min from the Trivet Study

Wendy Lim, MD, Mark Crowther, MD, Luqi Wang, James D. Douketis, MD, Terri Schnurr, Cathy Moreau, Catherine Clase, Marc Rodger, MD MSc, FRCPC, Erik Yeo, MD, Martine Leblanc, Philip McFarlane, Christine M. Ribic, MD

Blood (2016) 128 (22): 90.

https://doi.org/10.1182/blood.V128.22.90.90

Published: 2016

Journal Articles

Efficacy and Safety of Weight-Adjusted Extended Duration Tinzaparin for Prevention of Post-Operative Venous Thromboembolism after Bariatric Surgery

Deborah M. Siegal, MD MSc, Pankaj Handa, MD, Emma Kolesar, Mehran Anvari, MD, Maria Tiboni, MD, James D. Douketis, MD, Mark A. Crowther, MD MSc, FRCPC

Blood (2015) 126 (23): 1130.

https://doi.org/10.1182/blood.V126.23.1130.1130

Published: 2015

Journal Articles

Continued Use of Tinzaparin at Therapeutic Doses for Prophylaxis of Venous Thromboembolism in Patients with Intolerance to Antivitamins K

Maria Almudena Garcia Ruiz, DOCTOR AND HEMATOLOGY SPECIALIST, Francisco Jose Romero Martinez, DOCTOR, Estefania Morente Constantin, RESIDENT, Margarita Gomez Morales, DOCTOR AND HEMATOLOGIST, Manuel Jurado, MD

Blood (2015) 126 (23): 4735.

https://doi.org/10.1182/blood.V126.23.4735.4735

Published: 2015

Journal Articles

von Willebrand factor fibers promote cancer-associated platelet aggregation in malignant melanoma of mice and humans

Alexander T. Bauer, Jan Suckau, Kathrin Frank, Anna Desch, Lukas Goertz, Andreas H. Wagner, Markus Hecker, Tobias Goerge, Ludmila Umansky, Philipp Beckhove, Jochen Utikal, Christian Gorzelanny, Nancy Diaz-Valdes, Viktor Umansky, Stefan W. Schneider

Blood (2015) 125 (20): 3153–3163.

https://doi.org/10.1182/blood-2014-08-595686

Published: 2015

Includes: Multimedia, Supplemental data

Journal Articles

Long-Term Efficacy and Safety of Low-Molecular-Weight Heparins (LMWH) for Cancer-Associated Venous Thromboembolism (VTE) in Tropique, a Prospective Non-Interventional Observational Study

Dominique Farge, PhD MD, Philippe Debourdeau, MD, Norbert Claude Gorin, MD PhD, Anne Lamblin, Francis Cajfinger, MD

Blood (2014) 124 (21): 4273.

https://doi.org/10.1182/blood.V124.21.4273.4273

Published: 2014

Journal Articles

Long-Term Use of Low-Molecular-Weight Heparin (LMWH) for Cancer-Associated Venous Thromboembolism (VTE): Adherence to Recommendations in Clinical Practice Based on Tropique, a Prospective Non-Interventional Observational Study

Dominique Farge, PhD MD, Norbert Claude Gorin, MD PhD, Philippe Debourdeau, MD, Anne Lamblin, Francis Cajfinger, MD

Blood (2014) 124 (21): 1545.

https://doi.org/10.1182/blood.V124.21.1545.1545

Published: 2014

Journal Articles

A Randomized Trial of Long-Term Tinzaparin, a Low Molecular Weight Heparin (LMWH), Versus Warfarin for Treatment of Acute Venous Thromboembolism (VTE) in Cancer Patients - the CATCH Study

Agnes Y.Y. Lee, MD, Pieter W. Kamphuisen, MD PhD, Guy Meyer, MD, Rupert Bauersachs, MD, Mette S. Janas, MD PhD, Mikala F Jarner, MSc, Alok A. Khorana, MD on behalf of the CATCH Investigators

Blood (2014) 124 (21): LBA-2.

https://doi.org/10.1182/blood.V124.21.LBA-2.LBA-2

Published: 2014

Journal Articles

Thromboprophylaxis In Myeloma: A National Survey

Maeve P Crowley, MB BCh BAO, Barry M Kevane, MB BCh BAO, Joesph A Eustace, MB BCh MHS, Susan O'Shea, M.D, M.H.S, Oonagh M Gilligan, MB BAO BCh FRCPath

Blood (2013) 122 (21): 1694.

https://doi.org/10.1182/blood.V122.21.1694.1694

Published: 2013

NARROW

Validation of the Ottawa Score in Cancer Patients with Venous Thromboembolism. the Predicare Cohort Study

Updated Meta-Analysis of Randomized Controlled Trials on Primary Ambulatory Thromboprophylaxis (PATP) in Patients with Locally Advanced or Metastatic Lung Cancer Receiving Chemotherapy

Impact of Primary Ambulatory Thromboprophylaxis (PATP) with Low-Molecular Weight Heparins (LMWHs) on Survival in Patients with Locally Advanced or Metastatic Lung Cancer (LC) Receiving Chemotherapy

Impact of Anticoagulant and Antiplatelet on the Thrombotic Risk in Cancer Associated Thrombosis

Use of Anticoagulants of Patients with Cancer-Associated Thrombosis Beyond 6 Months ; The Uscat Study, a 432-Patient Retrospective Non-Interventional Study

Venous Thromboembolic Disease and Bone Marrow Transplant: A Remarkable Cause of Mortality and Morbidity — Potentially Preventable

Multi-Modal Mechanisms and Anti-Sickling of Novel Sulfated Non-Anticoagulant Low Molecular Weight Heparin in Sickle Cell Disease

Tackling Cancer Associated Thrombosis: A Multi-Professional Approach

Low- Molecular Weight Heparins (LMWH) Versus Vitamin K Antagonists (VKAs) in the Treatment and Secondary Prevention of Cancer-Associated Venous Thromboembolism (VTE): A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs)

Endothelial Protective Properties of Low Molecular Weight Heparin (LMWH) Tinzaparin in Combination with Statin: A Novel Potential Therapeutic Tool in Preventing Cancer Metastasis?

Safety of Weight-Adjusted Dosing of LMWH in Clinically Obese Cancer Patients with Venous Thromboembolism

The Risk of Major Bleeding with Low-Molecular-Weight-Heparins for Venous Thromboembolism in Dialysis Patients: The Q-VTE Study

Serial Trough Anti-Xa Levels to Assess Low Molecular Weight Heparin Accumulation in Patients with Chronic Kidney Disease: Analysis of Crcl <30 Ml/Min from the Trivet Study

Efficacy and Safety of Weight-Adjusted Extended Duration Tinzaparin for Prevention of Post-Operative Venous Thromboembolism after Bariatric Surgery

Continued Use of Tinzaparin at Therapeutic Doses for Prophylaxis of Venous Thromboembolism in Patients with Intolerance to Antivitamins K

von Willebrand factor fibers promote cancer-associated platelet aggregation in malignant melanoma of mice and humans

Long-Term Efficacy and Safety of Low-Molecular-Weight Heparins (LMWH) for Cancer-Associated Venous Thromboembolism (VTE) in Tropique, a Prospective Non-Interventional Observational Study

Long-Term Use of Low-Molecular-Weight Heparin (LMWH) for Cancer-Associated Venous Thromboembolism (VTE): Adherence to Recommendations in Clinical Practice Based on Tropique, a Prospective Non-Interventional Observational Study

A Randomized Trial of Long-Term Tinzaparin, a Low Molecular Weight Heparin (LMWH), Versus Warfarin for Treatment of Acute Venous Thromboembolism (VTE) in Cancer Patients - the CATCH Study

Thromboprophylaxis In Myeloma: A National Survey

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only